Diffuse Hemispheric Glioma, H3 G34-Mutant With Prominent Perivascular Invasion in a Middle-Aged Man: A Case Report and Literature Review of Middle-Aged and Elderly Cases. [PDF]
Yuzawa S+5 more
europepmc +1 more source
Des Basilius aus Achrida, Erzbischofs von Thessalonich, bisher unedierte Dialoge. Josef SchmidtRegula Antiqua Fratrum et Sororum seu Tertii Ordinis Sancti Francisci. Paul SabatierThe Development of Doctrine from the Early Middle Ages to the Reformation. John S. BanksThe Reformation Dawn. F. V. N. PainterLa controverse de l'apostolicité des églises de France au XIXe siècle. A. HoutinThe Crime of Christendom; Or, The Eastern Question from Its Origin to the Present Time. Daniel Seelye Gregory [PDF]
J. W. Moncrief
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
An Interesting Presentation of Hypercalcaemia in a Middle-Aged Male. [PDF]
Patel A, Siddique R, Khan A.
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Bertolotti Syndrome: Surgical Treatment in a Middle-Aged Triathlete-A Case Report. [PDF]
Mahler J, Alfieri A.
europepmc +1 more source
Microscopical Section from the Epiglottis of a Middle-aged Male Patient, with Supposed Tuberculosis [PDF]
James Dundas‐Grant
openalex +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
Sex-specific behavioral changes in middle-aged mice. [PDF]
Lou N+12 more
europepmc +1 more source